Elanco Animal Health Inc (ELAN)
13.15
-0.01
(-0.08%)
USD |
NYSE |
May 01, 16:00
13.15
0.00 (0.00%)
After-Hours: 20:00
Elanco Animal Health Enterprise Value: 11.92B for April 30, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 30, 2024 | 11.92B |
| April 29, 2024 | 12.13B |
| April 26, 2024 | 11.97B |
| April 25, 2024 | 11.87B |
| April 24, 2024 | 12.00B |
| April 23, 2024 | 12.07B |
| April 22, 2024 | 11.81B |
| April 19, 2024 | 11.82B |
| April 18, 2024 | 12.13B |
| April 17, 2024 | 12.05B |
| April 16, 2024 | 12.16B |
| April 15, 2024 | 12.28B |
| April 12, 2024 | 12.51B |
| April 11, 2024 | 12.71B |
| April 10, 2024 | 12.71B |
| April 09, 2024 | 12.97B |
| April 08, 2024 | 13.07B |
| April 05, 2024 | 13.11B |
| April 04, 2024 | 13.08B |
| April 03, 2024 | 13.05B |
| April 02, 2024 | 13.12B |
| April 01, 2024 | 13.31B |
| March 28, 2024 | 13.45B |
| March 27, 2024 | 13.39B |
| March 26, 2024 | 13.26B |
| Date | Value |
|---|---|
| March 25, 2024 | 13.27B |
| March 22, 2024 | 13.22B |
| March 21, 2024 | 13.46B |
| March 20, 2024 | 13.40B |
| March 19, 2024 | 13.15B |
| March 18, 2024 | 13.20B |
| March 15, 2024 | 13.17B |
| March 14, 2024 | 13.19B |
| March 13, 2024 | 13.27B |
| March 12, 2024 | 13.20B |
| March 11, 2024 | 13.32B |
| March 08, 2024 | 13.53B |
| March 07, 2024 | 13.45B |
| March 06, 2024 | 13.33B |
| March 05, 2024 | 13.30B |
| March 04, 2024 | 13.39B |
| March 01, 2024 | 13.32B |
| February 29, 2024 | 13.26B |
| February 28, 2024 | 13.28B |
| February 27, 2024 | 13.54B |
| February 26, 2024 | 13.44B |
| February 23, 2024 | 13.49B |
| February 22, 2024 | 13.38B |
| February 21, 2024 | 13.39B |
| February 20, 2024 | 13.38B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
8.410B
Minimum
May 21 2020
22.89B
Maximum
Aug 03 2021
14.71B
Average
13.25B
Median
Enterprise Value Benchmarks
| Merck & Co Inc | 355.33B |
| Catalent Inc | 14.87B |
| NanoString Technologies Inc | 143.03M |
| Cytokinetics Inc | 6.319B |
| Geron Corp | 1.892B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -141.00M |
| Revenue (Quarterly) | 1.035B |
| Total Expenses (Quarterly) | 1.025B |
| EPS Diluted (Quarterly) | -0.29 |
| Gross Profit Margin (Quarterly) | 50.14% |
| Profit Margin (Quarterly) | -13.62% |
| Earnings Yield | -19.01% |
| Operating Earnings Yield | 5.03% |
| Normalized Earnings Yield | -1.259 |